Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor

Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor

US Patent 11813274 · Granted Nov 14, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modeling interfaces with progressive cloth simulation2025
Pharmaceutical combination and composition, and combination preparation containi2025
Service level configuration method and apparatus2025
Service traffic adjustment method and apparatus2025
Method, device, and system for determining required bandwidth for data stream tr2025
Method for realizing splitting-rate multi-access of mobile cell-free massive MIM2025
Pharmaceutical combination containing glucose kinase activator and PPAR receptor2024
Prodrug of pyrrolidone derivatives as glucokinase activator2024
Pharmaceutical combination, composition, and combination preparation comprising 2024
Pharmaceutical combination, composition and compound preparation comprising gluc2024
Treating untreated or treatment-resistant diabetes with glucokinase activator2024
Treating untreated or treatment-resistant diabetes with glucokinase activator2024